Catimel G - Search Results

1

Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group.

Verweij J, Wanders J, Gil T, Schöffski P, Catimel G, te Velde A, de Mulder PH. Verweij J, et al. Among authors: catimel g. Br J Cancer. 1996 Feb;73(3):400-2. doi: 10.1038/bjc.1996.69. Br J Cancer. 1996. PMID: 8562350 Free PMC article. Clinical Trial.

2

Phase II clinical trials with rhizoxin in breast cancer and melanoma. The EORTC Early Clinical Trials Group.

Hanauske AR, Catimel G, Aamdal S, ten Bokkel Huinink W, Paridaens R, Pavlidis N, Kaye SB, te Velde A, Wanders J, Verweij J. Hanauske AR, et al. Among authors: catimel g. Br J Cancer. 1996 Feb;73(3):397-9. doi: 10.1038/bjc.1996.68. Br J Cancer. 1996. PMID: 8562349 Free PMC article. Clinical Trial.

3

Randomized study of a short course of weekly cisplatin with or without amifostine in advanced head and neck cancer. EORTC Head and Neck Cooperative Group.

Planting AS, Catimel G, de Mulder PH, de Graeff A, Höppener F, Verweij J, Oster W, Vermorken JB. Planting AS, et al. Among authors: catimel g. Ann Oncol. 1999 Jun;10(6):693-700. doi: 10.1023/a:1008353505916. Ann Oncol. 1999. PMID: 10442192 Free article. Clinical Trial.

4

Phase II studies of docetaxel in the treatment of various solid tumours. EORTC Early Clinical Trials Group and the EORTC Soft Tissue and Bone Sarcoma Group.

Verweij J, Catimel G, Sulkes A, Sternberg C, Wolff I, Aamdal S, van Hoesel Q. Verweij J, et al. Among authors: catimel g. Eur J Cancer. 1995;31A Suppl 4:S21-4. doi: 10.1016/0959-8049(95)00362-m. Eur J Cancer. 1995. PMID: 7577101 Clinical Trial.

5

Docetaxel (Taxotere): an active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

Catimel G, Verweij J, Mattijssen V, Hanauske A, Piccart M, Wanders J, Franklin H, Le Bail N, Clavel M, Kaye SB. Catimel G, et al. Ann Oncol. 1994 Jul;5(6):533-7. doi: 10.1093/oxfordjournals.annonc.a058908. Ann Oncol. 1994. PMID: 7918125 Free article. Clinical Trial.

6

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

Catimel G, Vermorken JB, Clavel M, de Mulder P, Judson I, Sessa C, Piccart M, Bruntsch U, Verweij J, Wanders J, et al. Catimel G, et al. Ann Oncol. 1994 Jul;5(6):543-7. doi: 10.1093/oxfordjournals.annonc.a058910. Ann Oncol. 1994. PMID: 7918127 Free article. Clinical Trial.

7

Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.

Schöffski P, Catimel G, Planting AS, Droz JP, Verweij J, Schrijvers D, Gras L, Schrijvers A, Wanders J, Hanauske AR. Schöffski P, et al. Among authors: catimel g. Ann Oncol. 1999 Jan;10(1):119-22. doi: 10.1023/a:1008360323986. Ann Oncol. 1999. PMID: 10076732 Free article. Clinical Trial.

8

Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study.

Wagener DJ, Verdonk HE, Dirix LY, Catimel G, Siegenthaler P, Buitenhuis M, Mathieu-Boué A, Verweij J. Wagener DJ, et al. Among authors: catimel g. Ann Oncol. 1995 Feb;6(2):129-32. doi: 10.1093/oxfordjournals.annonc.a059107. Ann Oncol. 1995. PMID: 7786820 Free article. Clinical Trial.

9

Phase II study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group.

van Hoesel QG, Verweij J, Catimel G, Clavel M, Kerbrat P, van Oosterom AT, Kerger J, Tursz T, van Glabbeke M, van Pottelsberghe C, et al. van Hoesel QG, et al. Among authors: catimel g. Ann Oncol. 1994 Jul;5(6):539-42. doi: 10.1093/oxfordjournals.annonc.a058909. Ann Oncol. 1994. PMID: 7918126 Free article. Clinical Trial.

10

KW-2149-induced pulmonary toxicity is not prevented by corticosteroids: a phase I and pharmacokinetic study.

Schrijvers D, Catimel G, Highley M, Höppener FJ, Dirix L, De Bruijn E, Droz JP, Van Oosterom AT. Schrijvers D, et al. Among authors: catimel g. Anticancer Drugs. 1999 Aug;10(7):633-9. doi: 10.1097/00001813-199908000-00002. Anticancer Drugs. 1999. PMID: 10507312 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

42 results

Search Page